Jiangsu Biomedicine has achieved remarkable results, and its output value increased by 16.4% in the first half of the year

 With the influx of massive demand, the explosive trend of the biomedical industry is both an accidental "fortune" and an inevitable trend
.
It is understood that the development of the biomedical industry in Jiangsu Province has achieved remarkable results in recent years.
Data shows that the output value of biomedicine in the first half of 2021 increased by 16.
4% year-on-year
.
The biopharmaceutical industry is related to the national economy and people's livelihood, and it is one of the areas with good growth and active development in the modern industrial system
.
Jiangsu is a province with a large economy and a large population.
The development of the biomedical industry is not only an important support for accelerating industrial transformation and upgrading and promoting high-quality development at the forefront, but also an urgent need to promote the construction of a "healthy Jiangsu" and enhance the people's sense of happiness and security.
Need
.
In order to better promote the development of the biomedical industry, in recent years, Jiangsu has introduced a number of policies and measures to break through the bottleneck of biomedical technology, focusing on the development of innovative drugs such as therapeutic antibodies, new vaccines, nucleic acid drugs, and peptide drugs to seize the commanding heights of innovation and build Develop the "new engine", and Jiangsu's pharmaceutical industry has entered the fast lane of high-quality development
.
For example, the "Several Policies and Measures on Promoting the High-Quality Development of the Province’s Biomedical Industry" recently issued by Jiangsu Province focus on industrial development goals, product development, review and approval, manufacturing, application promotion, talent introduction, and industrial ecology.
30 policy measures were put forward in various aspects, forming a "policy package" covering the entire industrial chain
.
With the help of favorable policies, Jiangsu's biomedical industry has developed rapidly
.
The data shows that in 2020, the output value of Jiangsu's biomedical industry accounted for about 1/6 of the country, and the output value in the first half of 2021 increased by 16.
4% year-on-year
.
In addition, data shows that in the first half of 2021, Jiangsu's pharmaceutical manufacturing increased by 49.
9%, and the biopharmaceutical manufacturing segment increased by 30.
5% year-on-year, with an average growth rate of more than 24% in both years
.
In terms of innovation capabilities, during the "13th Five-Year Plan" period, Jiangsu Province received a total of 15 innovative drugs, accounting for nearly 40% of the country
.
In 2020, the number of patent applications in the field of biomedicine in Jiangsu Province exceeded 10,000, and the number of authorized patents exceeded 5,000, and it was approved by the National Biopharmaceutical Technology Innovation Center
.
In addition, the regional characteristic clusters of Jiangsu Province have initially formed, Taizhou, Suzhou, Lianyungang, Nanjing and other cities have accelerated the creation of innovative industrial highlands, and 15 parks have been selected as "China's Top 50 Biomedical Industrial Parks in Comprehensive Competitiveness"
.
The author was also informed that in the first half of this year, companies in Suzhou City, Jiangsu Province were very vigorous to go public, the biomedical sector performed strongly, and the number of "listed corps" continued to increase.
Among them, 8 new companies entered the capital market.
The listing of these companies fully demonstrated Suzhou Biotechnology.
The "innovative power" and "hard power" of the pharmaceutical industry
.
Relying on the large scale of the industry and the agglomeration of leading pharmaceutical companies, Jiangsu Province is striving to become an industrial innovation highland with a complete system of innovation platforms in the field of biomedicine, strong corporate R&D capabilities, and high-quality industrial development
.
Increase policy and financial support, and treat clinical trial researchers equally in terms of promotion.
.
.
In recent years, Jiangsu has vigorously encouraged the province’s technological innovation in the fields of medicines and medical devices, accelerated industrial restructuring, transformation and upgrading, and improved industrial competitiveness , To achieve high-quality development
.
It is reported that through years of hard work, the basic capabilities of Jiangsu's biomedical industry and the modernization level of the industrial chain have been further improved, and the proportion of innovative drugs and high-end medical devices with independent intellectual property rights has increased significantly
.
In the future development, Jiangsu Province will continue to promote the development of the biomedical industry in a better direction
.
For example, according to the "14th Five-Year Plan for Pharmaceutical Industry Development of Jiangsu Province", during the "14th Five-Year Plan" period, the average annual growth rate of the pharmaceutical industry above designated size in Jiangsu Province will be maintained at about 10%, and the proportion of innovative products in the industrial structure will continue to increase.
, And strive to develop Jiangsu's pharmaceutical industry into an advanced manufacturing cluster with global influence and a world-renowned innovative drug highland by 2025
.